See more : HUTCHMED (China) Limited (HMDCF) Income Statement Analysis – Financial Results
Complete financial analysis of Rogers Corporation (ROG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rogers Corporation, a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
You may be interested
- Class 1 Nickel and Technologies Limited (NICO.CN) Income Statement Analysis – Financial Results
- Southern California Gas Company PFD SER A 6% (SOCGP) Income Statement Analysis – Financial Results
- PepGen Inc. (PEPG) Income Statement Analysis – Financial Results
- Horizon Space Acquisition I Corp. (HSPOU) Income Statement Analysis – Financial Results
- Leoch International Technology Limited (LCHIF) Income Statement Analysis – Financial Results
Rogers Corporation (ROG)
About Rogers Corporation
Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. It operates through Advanced Electronics Solutions (AES), Elastomeric Material Solutions (EMS), and Other segments. The AES segment offers circuit materials, ceramic substrate materials, busbars, and cooling solutions for applications in electric and hybrid electric vehicles (EV/HEV), wireless infrastructure, automotive, telematics and thermal solutions, aerospace and defense, mass transit, clean energy, connected devices, and wired infrastructure markets. This segment sells its products under the curamik, ROLINX, RO4000, RO3000, RT/duroid, CLTE Series, TMM, AD Series, DiClad, CuClad Series, Kappa, COOLSPAN, TC Series, 92ML, IsoClad, MAGTREX, XTremeSpeed RO1200, IM Series, 2929 Bondply, 3001 Bondply Film, and SpeedWave names. The EMS segment provides engineered material solutions, including polyurethane and silicone materials used in cushioning, gasketing, sealing, and vibration management applications; customized silicones used in flex heater and semiconductor thermal applications; and polytetrafluoroethylene and ultra-high molecular weight polyethylene materials used in wire and cable protection, electrical insulation, conduction and shielding, hose and belt protection, vibration management, cushioning, gasketing and sealing, and venting applications. This segment sells its products under the PORON, BISCO, DeWAL, ARLON, eSORBA, Griswold, XRD, Silicone Engineering, and R/bak names. The Other segment provides elastomer components; and elastomer floats for level sensing in fuel tanks, motors, and storage tanks for applications in the general industrial and automotive markets under the ENDUR and NITROPHYL names. Rogers Corporation was founded in 1832 and is headquartered in Chandler, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 908.40M | 971.17M | 932.89M | 802.58M | 898.26M | 879.09M | 821.04M | 656.31M | 641.44M | 610.91M | 537.48M | 498.76M | 553.15M | 379.19M | 291.82M | 365.36M | 431.35M | 454.56M | 356.11M | 365.00M | 243.33M | 219.44M | 216.04M | 248.22M | 247.80M | 216.60M | 189.70M | 141.50M | 140.30M | 133.90M | 123.20M | 172.40M | 182.40M | 190.30M | 174.90M | 162.50M | 145.30M | 128.80M | 125.30M |
| Cost of Revenue | 601.30M | 650.16M | 583.75M | 510.76M | 583.97M | 568.31M | 502.47M | 406.83M | 406.08M | 376.97M | 349.78M | 340.02M | 374.07M | 242.49M | 212.55M | 251.40M | 315.72M | 311.66M | 252.97M | 251.81M | 164.79M | 150.18M | 149.18M | 165.71M | 165.60M | 150.10M | 127.00M | 91.50M | 90.80M | 87.00M | 82.60M | 129.90M | 134.00M | 139.40M | 126.70M | 117.90M | 101.10M | 90.80M | 91.50M |
| Gross Profit | 307.10M | 321.02M | 349.14M | 291.82M | 314.29M | 310.78M | 318.58M | 249.49M | 235.36M | 233.94M | 187.70M | 158.75M | 179.08M | 136.70M | 79.28M | 113.96M | 115.64M | 142.90M | 103.15M | 113.19M | 78.54M | 69.26M | 66.86M | 82.51M | 82.20M | 66.50M | 62.70M | 50.00M | 49.50M | 46.90M | 40.60M | 42.50M | 48.40M | 50.90M | 48.20M | 44.60M | 44.20M | 38.00M | 33.80M |
| Gross Profit Ratio | 33.81% | 33.05% | 37.43% | 36.36% | 34.99% | 35.35% | 38.80% | 38.01% | 36.69% | 38.29% | 34.92% | 31.83% | 32.37% | 36.05% | 27.17% | 31.19% | 26.81% | 31.44% | 28.96% | 31.01% | 32.28% | 31.56% | 30.95% | 33.24% | 33.17% | 30.70% | 33.05% | 35.34% | 35.28% | 35.03% | 32.95% | 24.65% | 26.54% | 26.75% | 27.56% | 27.45% | 30.42% | 29.50% | 26.98% |
| Research & Development | 35.70M | 35.21M | 29.90M | 29.32M | 31.69M | 33.08M | 29.55M | 28.58M | 27.64M | 22.88M | 21.65M | 19.31M | 21.62M | 19.79M | 17.40M | 21.89M | 24.66M | 24.36M | 19.96M | 20.49M | 13.67M | 13.60M | 12.57M | 12.49M | 10.80M | 10.40M | 9.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 216.00M | 215.53M | 190.45M | 180.08M | 165.08M | 160.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -12.80M | 3.30M | 2.70M | 2.20M | 3.60M | 3.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 203.20M | 218.83M | 193.15M | 182.28M | 168.68M | 164.05M | 160.01M | 136.32M | 131.46M | 125.24M | 106.40M | 99.69M | 104.22M | 89.55M | 68.55M | 82.22M | 73.19M | 63.01M | 55.80M | 58.41M | 43.30M | 39.34M | 39.25M | 40.53M | 36.70M | 28.10M | 26.10M | 30.50M | 30.80M | 29.90M | 25.50M | 56.90M | 37.70M | 42.10M | 32.60M | 32.30M | 30.10M | 27.10M | 27.70M |
| Other Expenses | 0.00 | -144.01M | 5.33M | -104.00K | 959.00K | -994.00K | 3.38M | -1.79M | -8.49M | -1.19M | -1.24M | -208.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.40M | 8.40M | 6.60M | 5.80M | 5.70M | 6.70M | 6.70M | 10.90M | 11.70M | 11.20M | 10.60M | 9.60M | 8.60M | 7.30M | 5.90M |
| Operating Expenses | 221.80M | 110.02M | 228.39M | 211.50M | 201.33M | 194.03M | 189.56M | 164.90M | 159.11M | 148.12M | 128.04M | 119.00M | 125.84M | 109.34M | 85.94M | 104.10M | 97.84M | 98.64M | 75.76M | 78.90M | 56.97M | 52.93M | 51.82M | 53.02M | 57.90M | 46.90M | 42.30M | 36.30M | 36.50M | 36.60M | 32.20M | 67.80M | 49.40M | 53.30M | 43.20M | 41.90M | 38.70M | 34.40M | 33.60M |
| Cost & Expenses | 823.10M | 760.18M | 812.13M | 722.26M | 785.29M | 762.34M | 692.03M | 571.73M | 565.19M | 525.09M | 477.83M | 459.02M | 499.91M | 351.83M | 298.49M | 355.50M | 413.56M | 410.30M | 328.73M | 330.71M | 221.76M | 203.11M | 201.00M | 218.73M | 223.50M | 197.00M | 169.30M | 127.80M | 127.30M | 123.60M | 114.80M | 197.70M | 183.40M | 192.70M | 169.90M | 159.80M | 139.80M | 125.20M | 125.10M |
| Interest Income | 1.20M | 685.00K | 541.00K | 939.00K | 1.61M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 184.00K | 377.00K | 2.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 11.30M | 9.55M | 2.54M | 7.14M | 7.93M | 6.63M | 6.13M | 3.93M | 4.48M | 2.95M | 3.48M | 4.30M | 4.91M | 184.00K | 377.00K | 2.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 51.10M | 45.88M | 43.28M | 71.43M | 51.07M | 50.07M | 44.10M | 37.85M | 34.05M | 26.27M | 26.35M | 27.13M | 26.31M | 16.11M | 17.96M | 18.40M | 25.72M | 19.53M | 16.85M | 18.07M | 13.62M | 13.57M | 13.71M | 12.51M | 10.40M | 8.40M | 6.60M | 5.80M | 5.70M | 6.70M | 6.70M | 10.90M | 11.70M | 11.20M | 10.60M | 9.60M | 8.60M | 7.30M | 5.90M |
| EBITDA | 138.70M | 196.49M | 172.64M | 152.11M | 114.87M | 163.34M | 176.52M | 124.53M | 110.31M | 116.00M | 88.54M | 54.08M | 86.31M | 56.30M | 11.29M | 28.26M | 50.90M | 63.79M | 28.79M | 58.90M | 35.19M | 29.90M | 22.80M | 41.99M | 34.70M | 28.00M | 27.00M | 19.50M | 18.70M | 17.00M | 15.10M | -14.40M | 10.70M | 8.80M | 15.60M | 12.30M | 14.10M | 10.90M | 6.10M |
| EBITDA Ratio | 15.27% | 22.29% | 14.19% | 11.05% | 12.85% | 13.74% | 15.50% | 13.00% | 11.89% | 14.93% | 17.93% | 11.44% | 9.39% | 6.16% | 5.21% | 1.04% | 10.73% | 15.82% | 18.53% | 12.67% | 11.76% | 9.65% | 10.55% | 13.76% | 13.36% | 13.16% | 13.34% | 11.02% | 11.62% | 11.50% | 11.44% | -8.64% | 5.37% | 3.63% | 8.23% | 6.65% | 8.81% | 7.69% | 4.31% |
| Operating Income | 85.30M | 144.43M | 89.10M | 17.23M | 66.29M | 112.71M | 130.78M | 83.85M | 76.26M | 80.43M | 49.28M | 25.66M | 52.80M | 27.36M | -29.57M | 9.86M | 14.26M | 44.26M | 4.74M | 34.29M | 21.57M | 14.17M | 13.05M | 29.48M | 24.30M | 19.60M | 20.40M | 13.70M | 13.00M | 10.30M | 8.40M | -25.30M | -1.00M | -2.40M | 5.00M | 2.70M | 5.50M | 3.60M | 200.00K |
| Operating Income Ratio | 9.39% | 14.87% | 9.55% | 2.15% | 7.38% | 12.82% | 15.93% | 12.78% | 11.89% | 13.17% | 9.17% | 5.15% | 9.55% | 7.21% | -10.13% | 2.70% | 3.30% | 9.74% | 1.33% | 9.39% | 8.86% | 6.46% | 6.04% | 11.88% | 9.81% | 9.05% | 10.75% | 9.68% | 9.27% | 7.69% | 6.82% | -14.68% | -0.55% | -1.26% | 2.86% | 1.66% | 3.79% | 2.80% | 0.16% |
| Total Other Income/Expenses | -9.00M | -4.05M | 9.08M | 1.20M | -11.16M | -2.12M | 3.79M | 1.38M | -10.08M | -17.00K | -395.00K | -26.64M | 1.61M | 12.83M | -14.29M | 15.24M | 10.93M | 14.07M | 7.05M | 6.39M | 13.46M | 10.64M | 7.93M | 8.15M | 1.50M | -400.00K | 1.60M | 3.90M | 2.40M | 400.00K | 1.00M | -2.70M | -2.40M | -1.20M | -2.80M | -1.30M | -600.00K | -1.00M | -1.10M |
| Income Before Tax | 76.30M | 140.38M | 126.28M | 68.53M | 55.13M | 110.59M | 132.93M | 82.28M | 66.17M | 80.41M | 48.89M | 22.65M | 55.09M | 40.19M | -20.15M | 25.11M | 25.19M | 58.33M | 11.79M | 46.78M | 35.03M | 24.81M | 20.98M | 37.63M | 25.80M | 19.20M | 22.00M | 17.60M | 15.40M | 10.70M | 9.40M | -28.00M | -3.40M | -3.60M | 2.20M | 1.40M | 4.90M | 2.60M | -900.00K |
| Income Before Tax Ratio | 8.40% | 14.45% | 13.54% | 8.54% | 6.14% | 12.58% | 16.19% | 12.54% | 10.32% | 13.16% | 9.10% | 4.54% | 9.96% | 10.60% | -6.90% | 6.87% | 5.84% | 12.83% | 3.31% | 12.82% | 14.40% | 11.31% | 9.71% | 15.16% | 10.41% | 8.86% | 11.60% | 12.44% | 10.98% | 7.99% | 7.63% | -16.24% | -1.86% | -1.89% | 1.26% | 0.86% | 3.37% | 2.02% | -0.72% |
| Income Tax Expense | 19.70M | 23.75M | 18.15M | 18.54M | 7.81M | 22.94M | 52.47M | 34.00M | 19.85M | 27.53M | 11.23M | -46.48M | 11.28M | 5.62M | 42.72M | 3.49M | 3.32M | 11.88M | -4.65M | 6.68M | 8.76M | 6.20M | 5.25M | 10.91M | 7.20M | 5.40M | 5.50M | 3.70M | 2.30M | 600.00K | 1.70M | -1.60M | -1.10M | -1.20M | 600.00K | 400.00K | 1.50M | 300.00K | -1.70M |
| Net Income | 56.60M | 116.60M | 108.10M | 49.99M | 47.32M | 87.65M | 80.46M | 48.28M | 46.32M | 52.88M | 37.76M | 68.69M | 37.06M | 34.57M | -62.87M | 26.52M | 22.12M | 46.46M | 16.44M | 40.10M | 26.28M | 18.61M | 15.73M | 26.72M | 18.60M | 13.80M | 16.50M | 13.90M | 13.10M | 10.10M | 6.70M | -32.60M | -2.30M | -2.40M | 1.60M | 1.00M | 3.40M | 2.30M | 800.00K |
| Net Income Ratio | 6.23% | 12.01% | 11.59% | 6.23% | 5.27% | 9.97% | 9.80% | 7.36% | 7.22% | 8.66% | 7.03% | 13.77% | 6.70% | 9.12% | -21.54% | 7.26% | 5.13% | 10.22% | 4.62% | 10.99% | 10.80% | 8.48% | 7.28% | 10.76% | 7.51% | 6.37% | 8.70% | 9.82% | 9.34% | 7.54% | 5.44% | -18.91% | -1.26% | -1.26% | 0.91% | 0.62% | 2.34% | 1.79% | 0.64% |
| EPS | 3.04 | 6.21 | 5.77 | 2.68 | 2.55 | 4.77 | 4.43 | 2.68 | 2.52 | 2.94 | 2.23 | 4.18 | 2.31 | 2.19 | -4.01 | 1.69 | 1.34 | 2.77 | 1.01 | 2.41 | 1.83 | 1.20 | 1.03 | 1.79 | 0.62 | 0.91 | 0.56 | 0.48 | 0.46 | 0.71 | 0.14 | -2.63 | -0.19 | -0.20 | 0.04 | 0.02 | 0.07 | 0.05 | 0.02 |
| EPS Diluted | 3.03 | 6.15 | 5.73 | 2.67 | 2.53 | 4.70 | 4.34 | 2.65 | 2.48 | 2.86 | 2.16 | 4.04 | 2.21 | 2.16 | -4.01 | 1.67 | 1.32 | 2.69 | 0.98 | 2.30 | 1.77 | 1.16 | 0.98 | 1.69 | 0.60 | 0.87 | 0.53 | 0.46 | 0.43 | 0.69 | 0.13 | -2.63 | -0.19 | -0.20 | 0.04 | 0.02 | 0.07 | 0.05 | 0.02 |
| Weighted Avg Shares Out | 18.60M | 18.78M | 18.73M | 18.68M | 18.57M | 18.37M | 18.15M | 17.99M | 18.37M | 18.18M | 17.20M | 16.43M | 16.04M | 15.80M | 15.69M | 15.71M | 16.56M | 16.75M | 16.31M | 16.44M | 16.00M | 15.47M | 15.27M | 14.90M | 30.11M | 15.20M | 15.09M | 14.81M | 14.27M | 14.26M | 12.89M | 12.40M | 12.34M | 12.30M | 12.25M | 12.00M | 11.92M | 11.88M | 11.83M |
| Weighted Avg Shares Out (Dil) | 18.70M | 18.95M | 18.86M | 18.71M | 18.71M | 18.66M | 18.55M | 18.22M | 18.68M | 18.70M | 17.77M | 16.99M | 16.74M | 16.01M | 15.69M | 15.92M | 16.75M | 17.29M | 16.72M | 16.44M | 16.00M | 16.02M | 16.00M | 15.85M | 31.29M | 15.80M | 15.09M | 14.81M | 14.27M | 14.65M | 12.89M | 12.40M | 12.34M | 12.30M | 12.25M | 12.00M | 11.92M | 11.88M | 11.83M |
Rogers Corporation Welcomes Michael Webb as New Senior Vice President and Chief Administrative Officer
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”), announced that Michael Webb has joined the company as Senior Vice President and Chief Administrative Officer. He will be responsible for Global Human Resources and Corporate Development. Mike joins Rogers from Nutrien Ltd, where...
Rogers Schedules First Quarter 2023 Earnings Call for April 27
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”) plans to announce first quarter results on April 27 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President and...
Genentech Data Highlights Strength of Ophthalmology Portfolio and Commitment to Advancing Eye Care at ARVO 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data for its approved and investigational medicines will be highlighted in 30 abstracts at the 2023 Association for Research in...
Rogers Corporation Outlines Growth Strategy at Investor Day
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”) will outline its strategy for delivering significant revenue growth and profitability improvements at the Company's 2023 Investor Day event which is being held today at the New York Stock Exchange. The presentations will provide...
Rogers Corporation Outlines Growth Strategy at Investor Day
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”) will outline its strategy for delivering significant revenue growth and profitability improvements at the Company’s 2023 Investor Day event which is being held today at the New York Stock Exchange. The presentations will provide...
Rogers Corporation Welcomes Jessica Morton as New Vice President, General Counsel and Corporate Secretary
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”), announced that Jessica Morton has joined the company as Vice President, General Counsel and Corporate Secretary. Jessica joins Rogers from FMC Corporation, where she provided leadership for complex legal matters within areas including M&A...
Rogers Corporation Welcomes Jessica Morton as New Vice President, General Counsel and Corporate Secretary
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”), announced that Jessica Morton has joined the company as Vice President, General Counsel and Corporate Secretary. Jessica joins Rogers from FMC Corporation, where she provided leadership for complex legal matters within areas including M&A...
New Four-Year Data for Genentech’s Evrysdi Reinforce Long-Term Efficacy and Safety Profile in Some of the Most Severely Affected People With Types 2 and 3 Spinal Muscular Atrophy (SMA)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new long-term data for Evrysdi® (risdiplam) in a broad range of people aged 2-25 years with spinal muscular atrophy (SMA) from the...
Rogers Announces Nomination of Dr. Larry Berger as Independent Director at 2023 Annual Meeting of Shareholders
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE: ROG) (“Rogers” or the “Company”) today announced that its Board of Directors has nominated Dr. Larry Berger, Executive Vice President and Chief Technical Officer for Ecolab Inc., to stand for election as an independent Director...
Rogers Announces Nomination of Dr. Larry Berger as Independent Director at 2023 Annual Meeting of Shareholders
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE: ROG) (“Rogers” or the “Company”) today announced that its Board of Directors has nominated Dr. Larry Berger, Executive Vice President and Chief Technical Officer for Ecolab Inc., to stand for election as an independent Director...
Source: https://incomestatements.info
Category: Stock Reports